275 related articles for article (PubMed ID: 21457220)
1. Targeting of sodium channel blockers into nociceptors to produce long-duration analgesia: a systematic study and review.
Roberson DP; Binshtok AM; Blasl F; Bean BP; Woolf CJ
Br J Pharmacol; 2011 Sep; 164(1):48-58. PubMed ID: 21457220
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers.
Binshtok AM; Bean BP; Woolf CJ
Nature; 2007 Oct; 449(7162):607-10. PubMed ID: 17914397
[TBL] [Abstract][Full Text] [Related]
3. Acid solution is a suitable medium for introducing QX-314 into nociceptors through TRPV1 channels to produce sensory-specific analgesic effects.
Liu H; Zhang HX; Hou HY; Lu XF; Wei JQ; Wang CG; Zhang LC; Zeng YM; Wu YP; Cao JL
PLoS One; 2011; 6(12):e29395. PubMed ID: 22216270
[TBL] [Abstract][Full Text] [Related]
4. Coapplication of lidocaine and the permanently charged sodium channel blocker QX-314 produces a long-lasting nociceptive blockade in rodents.
Binshtok AM; Gerner P; Oh SB; Puopolo M; Suzuki S; Roberson DP; Herbert T; Wang CF; Kim D; Chung G; Mitani AA; Wang GK; Bean BP; Woolf CJ
Anesthesiology; 2009 Jul; 111(1):127-37. PubMed ID: 19512868
[TBL] [Abstract][Full Text] [Related]
5. Emulsified isoflurane enhances thermal transient receptor potential vanilloid-1 channel activation-mediated sensory/nociceptive blockade by QX-314.
Zhou C; Liang P; Liu J; Zhang W; Liao D; Chen Y; Chen X; Li T
Anesthesiology; 2014 Aug; 121(2):280-9. PubMed ID: 24667830
[TBL] [Abstract][Full Text] [Related]
6. Quaternary Lidocaine Derivative QX-314 Activates and Permeates Human TRPV1 and TRPA1 to Produce Inhibition of Sodium Channels and Cytotoxicity.
Stueber T; Eberhardt MJ; Hadamitzky C; Jangra A; Schenk S; Dick F; Stoetzer C; Kistner K; Reeh PW; Binshtok AM; Leffler A
Anesthesiology; 2016 May; 124(5):1153-65. PubMed ID: 26859646
[TBL] [Abstract][Full Text] [Related]
7. Bupivacaine-induced cellular entry of QX-314 and its contribution to differential nerve block.
Brenneis C; Kistner K; Puopolo M; Jo S; Roberson D; Sisignano M; Segal D; Cobos EJ; Wainger BJ; Labocha S; Ferreirós N; von Hehn C; Tran J; Geisslinger G; Reeh PW; Bean BP; Woolf CJ
Br J Pharmacol; 2014 Jan; 171(2):438-51. PubMed ID: 24117225
[TBL] [Abstract][Full Text] [Related]
8. Selectively targeting pain in the trigeminal system.
Kim HY; Kim K; Li HY; Chung G; Park CK; Kim JS; Jung SJ; Lee MK; Ahn DK; Hwang SJ; Kang Y; Binshtok AM; Bean BP; Woolf CJ; Oh SB
Pain; 2010 Jul; 150(1):29-40. PubMed ID: 20236764
[TBL] [Abstract][Full Text] [Related]
9. Permeation and block of TRPV1 channels by the cationic lidocaine derivative QX-314.
Puopolo M; Binshtok AM; Yao GL; Oh SB; Woolf CJ; Bean BP
J Neurophysiol; 2013 Apr; 109(7):1704-12. PubMed ID: 23303863
[TBL] [Abstract][Full Text] [Related]
10. Expression of TRPV1 channels after nerve injury provides an essential delivery tool for neuropathic pain attenuation.
Zakir HM; Mostafeezur RM; Suzuki A; Hitomi S; Suzuki I; Maeda T; Seo K; Yamada Y; Yamamura K; Lev S; Binshtok AM; Iwata K; Kitagawa J
PLoS One; 2012; 7(9):e44023. PubMed ID: 22962595
[TBL] [Abstract][Full Text] [Related]
11. The quaternary lidocaine derivative, QX-314, exerts biphasic effects on transient receptor potential vanilloid subtype 1 channels in vitro.
Rivera-Acevedo RE; Pless SA; Ahern CA; Schwarz SK
Anesthesiology; 2011 Jun; 114(6):1425-34. PubMed ID: 21502857
[TBL] [Abstract][Full Text] [Related]
12. Cellular permeation of large molecules mediated by TRPM8 channels.
McCoy DD; Palkar R; Yang Y; Ongun S; McKemy DD
Neurosci Lett; 2017 Feb; 639():59-67. PubMed ID: 28038937
[TBL] [Abstract][Full Text] [Related]
13. Phenotyping the function of TRPV1-expressing sensory neurons by targeted axonal silencing.
Brenneis C; Kistner K; Puopolo M; Segal D; Roberson D; Sisignano M; Labocha S; Ferreirós N; Strominger A; Cobos EJ; Ghasemlou N; Geisslinger G; Reeh PW; Bean BP; Woolf CJ
J Neurosci; 2013 Jan; 33(1):315-26. PubMed ID: 23283344
[TBL] [Abstract][Full Text] [Related]
14. Prolonged analgesic response of cornea to topical resiniferatoxin, a potent TRPV1 agonist.
Bates BD; Mitchell K; Keller JM; Chan CC; Swaim WD; Yaskovich R; Mannes AJ; Iadarola MJ
Pain; 2010 Jun; 149(3):522-528. PubMed ID: 20403666
[TBL] [Abstract][Full Text] [Related]
15. Gold nanorods-based thermosensitive hydrogel produces selective long-lasting regional anesthesia triggered by photothermal activation of Transient Receptor Potential Vanilloid Type-1 channels.
Zhou C; Huang J; Yang Q; Li T; Liu J; Qian Z
Colloids Surf B Biointerfaces; 2018 Nov; 171():17-23. PubMed ID: 30005286
[TBL] [Abstract][Full Text] [Related]
16. Neuroscience: a local route to pain relief.
McCleskey EW
Nature; 2007 Oct; 449(7162):545-6. PubMed ID: 17914381
[No Abstract] [Full Text] [Related]
17. External QX-314 inhibits evoked cranial primary afferent synaptic transmission independent of TRPV1.
Hofmann ME; Largent-Milnes TM; Fawley JA; Andresen MC
J Neurophysiol; 2014 Dec; 112(11):2697-706. PubMed ID: 25185814
[TBL] [Abstract][Full Text] [Related]
18. Nociceptor-selective peripheral nerve block induces delayed mechanical hypersensitivity and neurotoxicity in rats.
Peters CM; Ririe D; Houle TT; Aschenbrenner CA; Eisenach JC
Anesthesiology; 2014 Apr; 120(4):976-86. PubMed ID: 24296762
[TBL] [Abstract][Full Text] [Related]
19. The quaternary lidocaine derivative QX-314 produces long-lasting intravenous regional anesthesia in rats.
Zhao Y; Zhou C; Liu J; Liang P; Liao D; Chen Y; Chen X
PLoS One; 2014; 9(6):e99704. PubMed ID: 24932639
[TBL] [Abstract][Full Text] [Related]
20. Duration and local toxicity of sciatic nerve blockade with coinjected site 1 sodium-channel blockers and quaternary lidocaine derivatives.
Shankarappa SA; Sagie I; Tsui JH; Chiang HH; Stefanescu C; Zurakowski D; Kohane DS
Reg Anesth Pain Med; 2012; 37(5):483-9. PubMed ID: 22914659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
